Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LY2605541 vs Insulin NPH in Insulin-Naïve T2DM
NCT01790438Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Mar 2013
- Primary completion
- May 2014
- Modality
- Polymer-based Nanoparticles, Recombinant Proteins and Enzymes
- Countries
- 11
01
Overview
A Phase 3 trial of insulin peglispro in type 2 diabetes mellitus (T2DM), sponsored by Eli Lilly and Company. Started Mar 2013; status: completed.
02
Drugs
insulin peglispro
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01790438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01790438.